MacroGenics, Inc. (MGNX): Price and Financial Metrics
MGNX Price/Volume Stats
| Current price | $3.18 | 52-week high | $21.88 |
| Prev. close | $3.18 | 52-week low | $2.95 |
| Day low | $3.13 | Volume | 722,100 |
| Day high | $3.26 | Avg. volume | 1,372,150 |
| 50-day MA | $3.65 | Dividend yield | N/A |
| 200-day MA | $6.55 | Market Cap | 199.59M |
MGNX Stock Price Chart Interactive Chart >
MacroGenics, Inc. (MGNX) Company Bio
Macrogenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer, as well as autoimmune disorders and infectious diseases. The company was founded in 2000 and is based in Rockville, Maryland.
MGNX Price Returns
| 1-mo | -0.93% |
| 3-mo | -3.05% |
| 6-mo | -29.33% |
| 1-year | -67.78% |
| 3-year | -81.47% |
| 5-year | -71.14% |
| YTD | -66.94% |
| 2023 | 43.37% |
| 2022 | -58.19% |
| 2021 | -29.79% |
| 2020 | 110.11% |
| 2019 | -14.33% |
Continue Researching MGNX
Want to do more research on Macrogenics Inc's stock and its price? Try the links below:Macrogenics Inc (MGNX) Stock Price | Nasdaq
Macrogenics Inc (MGNX) Stock Quote, History and News - Yahoo Finance
Macrogenics Inc (MGNX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...